Unity Biotechnology, Inc.UBXNASDAQ
Loading
| Metric | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | -30.18% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | -60.26% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +17.27% | +16.56% | +15.42% | +6.88% | +0.51% |
| Weighted Average Shares Diluted Growth | +17.27% | +16.56% | +15.42% | +6.88% | +0.51% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -100.00% | -100.00% | -91.19% | -100.00% |
| Inventory Growth | +0.00% | -100.00% | -100.00% | +0.00% | +0.00% |
| Asset Growth | -48.48% | -47.01% | -31.96% | -42.67% | -48.44% |
| Book Value per Share Growth | -65.11% | -65.70% | -66.15% | -78.60% | +0.00% |
| Debt Growth | -44.16% | -45.43% | -15.28% | -12.79% | -13.55% |
| R&D Expense Growth | -34.52% | -46.96% | -43.13% | -7.21% | -27.45% |
| SG&A Expenses Growth | -15.92% | -35.28% | -13.84% | -2.83% | +1.68% |